FDAnews
www.fdanews.com/articles/82092-accentia-biopharmaceuticals-announces-pricing-of-initial-public-offering

ACCENTIA BIOPHARMACEUTICALS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING

November 1, 2005

Accentia Biopharmaceuticals, Inc. announced today the pricing of its initial public offering of 2,400,000 shares of its common stock at a price to the public of $8.00 per share. All of the shares are being offered by Accentia. In addition, Accentia has granted to the underwriters a 30-day option to purchase up to an additional 360,000 shares to cover over-allotments, if any. Accentia's common stock will be listed on the Nasdaq National Market under the symbol "ABPI." The offering is expected to close on November 2, 2005.
Business Wire